Cristin Hubbard's most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 2,155 Common Stock done at an average price of $59.9 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.93 per share. | 20 May 2025 | 2,155 | 30,545 (0%) | 0% | 59.9 | 129,149 | Common Stock |
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 64.92 per share. | 02 May 2025 | 273 | 32,700 (0%) | 0% | 64.9 | 17,723 | Common Stock |
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 54.14 per share. | 02 May 2025 | 273 | 32,973 (0%) | 0% | 54.1 | 14,779 | Common Stock |
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 30,880 | 30,880 | - | - | Stock Option (Right to Buy Common Stock) | |
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 13,310 | 32,700 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | 20 May 2024 | 33,520 | 33,520 | - | - | Stock Option (Right to Buy Common Stock) | ||
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | 20 May 2024 | 14,690 | 14,690 (0%) | 0% | 0 | Common Stock | ||
| Biomarin Pharmaceutical Inc | Cristin Hubbard | EVP, Chief Commercial Officer | 20 May 2024 | 4,700 | 19,390 (0%) | 0% | 0 | Common Stock |